Qbd-based optimization and formulation of doxorubicin bcl-2 sirna-loaded sphingosomes

HIGHLIGHTS

  • What: The study shows how to use a complete factorial design to optimize a sphiongosome for the treatment of lung cancer.
  • Who: Int. J. Pharm. Investigation and colleagues from the Department of Pharmaceutics, NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Deralakatte, Mangalore have published the Article: Original Article, in the Journal: (JOURNAL)
  • Future: Future studies could further refine these models

SUMMARY

    Sphingosomes, a prominent lipid vesicle drug delivery system, features a membranous lipid bilayer enclosing an aqueous space for drug entrapment. Response Surface Methodology (RSM) and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?